Health Catalyst, Inc
HCAT
Positions held
Your positionsHCAT isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $131.70M | Enterprise value | $198.24M | Trailing P/E | — | Forward P/E | 233.33 |
| PEG | — | Price / book | 1.29 | Beta | 1.54 | Dividend yield | 0.00% |
| Revenue growth | -12.7% | Earnings growth | — | Gross margin | 51.2% | Operating margin | -5.3% |
| Profit margin | -90.6% | ROE | -118.1% | ROA | -3.0% | Debt / equity | 1.69 |
| Current ratio | 2.70 | Free cash flow | -$48.65M | Analyst recommendation | hold | Mean target | $1.77 |
| 52w high | $3.62 | 52w low | $0.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $70.5M | $70.8M | $74.7M | $76.3M | $80.7M | — |
| Op margin | -13.4% | -10.1% | 4.4% | -22.9% | -10.3% | — |
| Net income | -$40.5M | -$111M | -$91.0M | -$22.2M | -$41.0M | — |
| Gross margin | 49.5% | 50.1% | 52.7% | 49.5% | 47.4% | — |
| Gross profit | $34.9M | $35.5M | $39.4M | $37.8M | $38.2M | — |
| Operating income | -$9.4M | -$7.2M | $3.3M | -$17.5M | -$8.3M | — |
- Revenue -0% vs prior quarter ($70M vs $71M).
- Gross margin 49.5% (was 50.1% prior quarter).
- Operating margin compressed to -13.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $311M | $307M | $296M | $276M | — |
| Op margin | -13.7% | -18.8% | -33.8% | -50.7% | — |
| Net income | -$178M | -$69.5M | -$118M | -$137M | — |
| Gross margin | 48.7% | 45.9% | 44.5% | 48.2% | — |
| Gross profit | $152M | $141M | $132M | $133M | — |
| Operating income | -$42.7M | -$57.6M | -$100.0M | -$140M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · Health Catalyst (HCAT): Buy, Sell, or Hold Post Q2 Earnings?
2026-09-28 · 3 Software Stocks We’re Skeptical Of
2026-09-25 · 3 Unprofitable Stocks That Fall Short
2026-09-19 · Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks
2026-09-18 · 3 Small-Cap Stocks We Steer Clear Of
2026-09-14 · Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-09-14 · Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
2026-09-11 · 3 Value Stocks That Concern Us
2026-09-10 · Health Catalyst appoints new CEO
2026-09-08 · Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
2026-08-31 · Health Catalyst to Participate in Upcoming Investor Conference
Price (daily)
Full chart · RSI · MACD · patterns